Table 2.

Pearson Correlation Between Clinical and Biochemical Variables With Serum F/E Ratio, Serum Cortisone, and Serum Cortisol in All of the Subjects Studied

Serum F/E Ratio
Serum Cortisone
Serum Cortisol
CharacteristicsrPrPrP
Age0.120.16−0.300.0006a−0.050.58
BMI, kg/m20.340.0001a−0.240.007a0.160.08
Systolic BP, mm Hg0.390.0001a−0.100.310.260.003a
Diastolic BP, mm Hg0.250.005a−0.180.04a0.140.11
SA, ng/dL0.030.670.160.080.110.22
PRA, ng/mL*h−0.030.710.410.0001a0.160.06
Serum potassium, mEq/L−0.240.007a0.150.08−0.140.12
MAC, mg/24 h0.230.01a−0.070.440.100.29
FEK 24 h, %0.290.001a−0.250.005a−0.100.29
hs-CRP, mg/L0.240.008a−0.150.090.100.29
PAI-1, µg/L0.080.40−0.080.380.030.75
TNF-α, ng/L0.260.004a−0.180.050.080.38
IL-6, ng/L−0.190.070.010.88−0.140.17
MMP9 activity, fold change0.080.390.040.690.100.34
MMP2 activity, fold change0.010.900.030.710.0010.99
Serum F/E Ratio
Serum Cortisone
Serum Cortisol
CharacteristicsrPrPrP
Age0.120.16−0.300.0006a−0.050.58
BMI, kg/m20.340.0001a−0.240.007a0.160.08
Systolic BP, mm Hg0.390.0001a−0.100.310.260.003a
Diastolic BP, mm Hg0.250.005a−0.180.04a0.140.11
SA, ng/dL0.030.670.160.080.110.22
PRA, ng/mL*h−0.030.710.410.0001a0.160.06
Serum potassium, mEq/L−0.240.007a0.150.08−0.140.12
MAC, mg/24 h0.230.01a−0.070.440.100.29
FEK 24 h, %0.290.001a−0.250.005a−0.100.29
hs-CRP, mg/L0.240.008a−0.150.090.100.29
PAI-1, µg/L0.080.40−0.080.380.030.75
TNF-α, ng/L0.260.004a−0.180.050.080.38
IL-6, ng/L−0.190.070.010.88−0.140.17
MMP9 activity, fold change0.080.390.040.690.100.34
MMP2 activity, fold change0.010.900.030.710.0010.99
a

Correlation was considered significant at the 0.05 level.

Table 2.

Pearson Correlation Between Clinical and Biochemical Variables With Serum F/E Ratio, Serum Cortisone, and Serum Cortisol in All of the Subjects Studied

Serum F/E Ratio
Serum Cortisone
Serum Cortisol
CharacteristicsrPrPrP
Age0.120.16−0.300.0006a−0.050.58
BMI, kg/m20.340.0001a−0.240.007a0.160.08
Systolic BP, mm Hg0.390.0001a−0.100.310.260.003a
Diastolic BP, mm Hg0.250.005a−0.180.04a0.140.11
SA, ng/dL0.030.670.160.080.110.22
PRA, ng/mL*h−0.030.710.410.0001a0.160.06
Serum potassium, mEq/L−0.240.007a0.150.08−0.140.12
MAC, mg/24 h0.230.01a−0.070.440.100.29
FEK 24 h, %0.290.001a−0.250.005a−0.100.29
hs-CRP, mg/L0.240.008a−0.150.090.100.29
PAI-1, µg/L0.080.40−0.080.380.030.75
TNF-α, ng/L0.260.004a−0.180.050.080.38
IL-6, ng/L−0.190.070.010.88−0.140.17
MMP9 activity, fold change0.080.390.040.690.100.34
MMP2 activity, fold change0.010.900.030.710.0010.99
Serum F/E Ratio
Serum Cortisone
Serum Cortisol
CharacteristicsrPrPrP
Age0.120.16−0.300.0006a−0.050.58
BMI, kg/m20.340.0001a−0.240.007a0.160.08
Systolic BP, mm Hg0.390.0001a−0.100.310.260.003a
Diastolic BP, mm Hg0.250.005a−0.180.04a0.140.11
SA, ng/dL0.030.670.160.080.110.22
PRA, ng/mL*h−0.030.710.410.0001a0.160.06
Serum potassium, mEq/L−0.240.007a0.150.08−0.140.12
MAC, mg/24 h0.230.01a−0.070.440.100.29
FEK 24 h, %0.290.001a−0.250.005a−0.100.29
hs-CRP, mg/L0.240.008a−0.150.090.100.29
PAI-1, µg/L0.080.40−0.080.380.030.75
TNF-α, ng/L0.260.004a−0.180.050.080.38
IL-6, ng/L−0.190.070.010.88−0.140.17
MMP9 activity, fold change0.080.390.040.690.100.34
MMP2 activity, fold change0.010.900.030.710.0010.99
a

Correlation was considered significant at the 0.05 level.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close